Ubiquitination in cancer: mechanisms and therapeutic opportunities
Cancer Communications · 2025-09 · 45 (9) · 1128-1161
DOI: 10.1002/cac2.70044 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Communications, online erschienen am 19.06.2025. Verfasst von Susi Zhu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Xiangya Hospital, Central South University, Changsha, Hunan, P. R. China. Hauptthemen laut MEDLINE: Ubiquitination, Neoplasms. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 323 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, National Natural Science Foundation of Hunan Province, the Program of Introducing Talents of Discipline to Universities.
Abstract (Originalsprache)
Ubiquitination, a key post‐translational modification, plays an essential role in tumor biology by regulating fundamental cellular processes, such as metabolism and cell death. Additionally, it interacts with other post‐translational modifications, which are closely linked to tumorigenesis, tumor progression, the tumor microenvironment, and the response to therapeutic interventions. Recent advancements in understanding the ubiquitination mechanisms have led to significant breakthroughs, offering novel perspectives and strategies for diagnosing and treating tumors. Here, we provided an overview of how ubiquitination influences tumor biology, focusing on its roles in immune regulation, metabolism, and its interactions with other modifications. We also summarized the clinical potential of targeting E3 ubiquitin ligases and deubiquitinases as therapeutic strategies in cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Xiangya Hospital, Central South University, Changsha, Hunan, P. R. China.
- National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology, Xiangya Hospital, Central South University, Changsha, Hunan, P. R. China.
- Furong Laboratory, Central South University, Changsha, Hunan, P. R. China.
- Hunan Key Laboratory of Skin Cancer and Psoriasis, Human Engineering Research Center of Skin Health and Disease, Xiangya Hospital, Central South University, Changsha, Hunan, P. R. China.
- National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, P. R. China.
ORCID-Profile: Cong Peng
Förderung
- National Natural Science Foundation of China
- National Natural Science Foundation of Hunan Province
- the Program of Introducing Talents of Discipline to Universities
- The Fundamental Research Funds for the Central Universities of Central South University
Zitieren
APA
Zhu, S., Zhang, X., Liu, W., Zhou, Z., Xiong, S., Li, J., Chen, X., & Peng, C. (2025). Ubiquitination in cancer: mechanisms and therapeutic opportunities. Cancer Communications, 45(9), 1128-1161. https://doi.org/10.1002/cac2.70044
Vancouver
Zhu S, Zhang X, Liu W, Zhou Z, Xiong S, Li J, et al. Ubiquitination in cancer: mechanisms and therapeutic opportunities. Cancer Communications. 2025;45(9):1128-1161. doi:10.1002/cac2.70044
BibTeX
@article{Zhu2025,
author = {Zhu, Susi and Zhang, Xu and Liu, Waner and Zhou, Zhe and Xiong, Siyu and Li, Jie and Chen, Xiang and Peng, Cong},
title = {Ubiquitination in cancer: mechanisms and therapeutic opportunities},
journal = {Cancer Communications},
year = {2025},
volume = {45},
number = {9},
pages = {1128--1161},
doi = {10.1002/cac2.70044}
}
EUVIMED